Vaso Corporation is a diversified medical technology company with several distinctive but related specialties: managed IT systems and services, including healthcare software solutions and network connectivity services; professional sales services for diagnostic imaging products; and design, manufacture and sale of proprietary medical devices.
Company profile
Ticker
VASO
Exchange
Website
CEO
Jun Ma
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
VASOMEDICAL INC, VASOMEDICAL, INC
SEC CIK
Corporate docs
Subsidiaries
Vaso Diagnostics, Inc. • VasoMedical, Inc. • Vasomedical Global Corp. • Vasomedical Solutions, Inc. • VasoHealthcare IT Corp. • VasoTechnology, Inc. • NetWolves Network Services LLC • EECP Global Corporation • Fast Growth Enterprises Limited ...
IRS number
112871434
VASO stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
1 Apr 24
PREM14A
Preliminary proxy related to merger
6 Mar 24
8-K
Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger
7 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Departure of Directors or Certain Officers
3 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
DEF 14A
Definitive proxy
3 Oct 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 11.06 mm | 11.06 mm | 11.06 mm | 11.06 mm | 11.06 mm | 11.06 mm |
Cash burn (monthly) | 1.11 mm | 185.67 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 7.42 mm | 1.24 mm | n/a | n/a | n/a | n/a |
Cash remaining | 3.63 mm | 9.82 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 3.3 | 52.9 | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2022
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 45.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Captrust Financial Advisors | 45.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Apr 23 | Joshua Markowitz | Common Stock | Other | Acquire J | Yes | No | 0 | 55,738,318 | 0.00 | 56,088,318 |